ORIC Pharmaceuticals Inc. (ORIC) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ORIC Pharmaceuticals Inc.

    NASDAQ: ORIC · Real-Time Price · USD
    11.56
    0.24 (2.12%)
    At close: Oct 03, 2025, 3:59 PM
    11.55
    -0.13%
    Pre-market: Oct 06, 2025, 08:41 AM EDT

    ORIC Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -4.4 -4.7 -2.62 -7.09
    PEG Ratio
    		 0.66 0.36 -0.3 0.18
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 2.31 2.11 1.05 2.04
    P/FCF Ratio
    		 -4.94 -5.47 -3.02 -9.22
    P/OCF Ratio
    		 -4.99 -5.52 -3.11 -9.37
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.04 0.05 0.01 0.01
    Quick Ratio
    		 10.56 10.39 13.68 15.87
    Current Ratio
    		 10.56 10.39 13.68 15.87
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -34.69 n/a
    Return on Equity
    		 -0.53 -0.45 -0.4 -0.29
    Return on Assets
    		 -0.47 -0.4 -0.36 -0.26
    Return on Invested Capital
    		 -0.56 -0.47 -0.4 -0.27
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist